荣筋片治疗肾虚血瘀型原发性骨质疏松症的临床疗效观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

天津市卫生局课题《叶氏伤科正骨临证经验的挖掘及整理》(编号:20110179)


The Clinical Efficacy of Rongjin Tablets in Treating the Kidney Deficiency and Blood Stasis Type of Primary Osteoporosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察院内制剂荣筋片治疗肾虚血瘀型原发性骨质疏松症的临床疗效。方法:将61例肾虚血瘀型原发性骨质疏松症患者随机分为2组。治疗组31例,服用荣筋片、罗盖全和钙尔奇D;对照组30例,服用罗盖全和钙尔奇D,2组均以4周为1个疗程,6个疗程后统计疗效。结果:总有效率治疗组为93.5%,对照组为73.3%,治疗组优于对照组,差异有统计学意义(P<0.05)。结论:荣筋片治疗肾虚血瘀型原发性骨质疏松症具有一定的临床疗效。

    Abstract:

    To observe the clinical efficacy of Rongjin tablets in treating the kidney deficiency and blood stasis type of primary osteoporosis. Methods:Sixty one patients of the kidney deficiency and blood stasis type of primary osteoporosis were randomly divided into two groups,31cases in the treatment group treated with oral administration of Rongjin tablets, calcitriol soft gelatin capsules and Vitamin D Calcium Chewable Tablets and 30 cases in the control group given oral administration of calcitriol soft gelatin capsules and Vitamin D Calcium Chewable Tablets. 4 weeks was a course of treatment and the clinical curative effect was observed after 6 courses of treatment. Results:The total effective rate in the treatment group was 93.5%,while that in the control group was 73.3%; the treatment group showed better efficacy than the control group, and the difference was significant(P<0.05). Conclusion: Rongjin tablets can achieve significant effect in treating the kidney deficiency and blood stasis type of primary osteoporosis.

    参考文献
    相似文献
    引证文献
引用本文

李远栋 王 平 王为民 古恩鹏 杨 光 刘爱峰 张 超.荣筋片治疗肾虚血瘀型原发性骨质疏松症的临床疗效观察[J].世界中医药,2013,8(10).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2012-12-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2013-10-31
  • 出版日期:
文章二维码